Julien Mamet serves as Executive at Alliqua BioMedical, Inc., where they oversee executive responsibilities. Since joining the company, Julien Mamet has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 3, 2019 involved receiving (via award) 240,454 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| May 3, 2019 | ADYX | $0 | Award | 240,454 | $N/A | Discretionary |
Julien Mamet currently holds 240,454 shares of Alliqua BioMedical, Inc. (ADYX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Julien Mamet has been a net neutral trader of ADYX stock. They have purchased $0 and sold $0 worth of shares.
Julien Mamet's most recent insider trade was on May 3, 2019, when they sold 240,454 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted